Syndax to Announce First Quarter 2020 Financial Results and Host Conference Call and Webcast on May 7, 2020

WALTHAM, Mass., April 30, 2020 /PRNewswire/ — Syndax Pharmaceuticals, Inc. (“Syndax,” the “Company” or “we”) (Nasdaq:SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, announced today that it will release its first quarter 2020…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.